Renowned as a research services provider, our company excels in pioneering drug therapies for rare kidney diseases. Supported by a team of leading scientists, we drive innovation and achieve significant milestones in drug discovery and development. As a specialized provider of preclinical research services for rare kidney diseases, we offer a distinct set of advantages that position us as the premier partner of choice for pharmaceutical companies and research institutions. We offer end-to-end services covering the entire drug discovery and preclinical development process, including in vitro assays, in vivo studies, pharmacokinetics, and toxicology.